RxDoctor Payments Data

Dov Grant

Gastroenterology · New York, NYNPI 1164501219

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.1% of the total across 216 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 39.6% of the total. Reporting peaked in 2022 at $1,083 and has fallen 79.5% since, to $222 in 2023.

$2,839in general payments, 2019–2025

Across 216 payments — averaging $13.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • QOL Medical, LLC$534
  • AbbVie$294
  • Merck$268
  • Braintree Laboratories, Inc.$150
  • AstraZeneca$84
  • plus $384 from 14 others

What the payments were for

  • Food & beverage$2,81499%
  • Education$130%
  • Other$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,839 in reported general payments places this provider in the 55th percentile of 1,682 gastroenterology providers in New York.

See all gastroenterology providers in New York →

Other gastroenterology in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →